Non-visible haematuria: would discontinuing urgent investigation have a visible impact?
Br J Hosp Med (Lond)
; 81(4): 1-7, 2020 Apr 02.
Article
in En
| MEDLINE
| ID: mdl-32339006
ABSTRACT
National guidance in the UK continues to recommend urgent referral of selected patients with non-visible haematuria for urological assessment. The positive predictive value of non-visible haematuria for urological cancer is low, so it is uncertain whether this is an effective and equitable use of healthcare resources. This article considers rationales for and against continuing this practice, and outlines alternative investigative strategies for patients presenting with non-visible haematuria based on current knowledge and modern technology.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Referral and Consultation
/
Urologic Neoplasms
/
Hematuria
Type of study:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Br J Hosp Med (Lond)
Journal subject:
HOSPITAIS
/
MEDICINA
Year:
2020
Type:
Article
Affiliation country:
United kingdom